22nd Century Group Appoints Nora B. Sullivan to Board of Directors
May 22 2015 - 1:46PM
Business Wire
22nd Century Group, Inc. (NYSE MKT:XXII), a leader in tobacco
harm reduction, announced today that the Company appointed Nora B.
Sullivan to 22nd Century Group’s Board of Directors, effective May
18, 2015.
Ms. Sullivan has made a career of applying her legal experience
and financial services expertise to focus on strategic planning,
corporate governance matters, and M&A services. Ms. Sullivan is
currently President of Sullivan Capital Partners, LLC, a financial
services company providing investment banking and consulting
services to closely-held businesses.
Prior to founding Sullivan Capital Partners in 2004, Ms.
Sullivan worked for The Citigroup Private Bank from 2000 to 2004,
providing wealth management and private equity services to high net
worth individuals. From 1995 to 1999, Ms. Sullivan was Executive
Vice President of Rand Capital Corporation (NASDAQ: RAND), a
publicly traded closed-end investment management company providing
capital and managerial expertise to small and mid-size businesses.
Ms. Sullivan is a member of the Boards of Directors of Evans
Bancorp, Inc. (NYSE: EVBN), Independent Health, Robinson Home
Products, and Rosina Food Products. She is Chairman of the
Technology Transfer Committee of the Roswell Park Cancer Institute
Board. Ms. Sullivan holds an MBA degree in Finance and
International Business from Columbia University Graduate School of
Business and a JD degree from the University of Buffalo School of
Law.
“I am delighted that Nora has chosen to join 22nd Century’s
Board of Directors,” said James W. Cornell, Chairman of the Board
of 22nd Century Group. “As a highly respected financial
professional, Nora’s experience, contacts, and public market
insights will be invaluable to our Company.”
About 22nd Century Group, Inc.
22nd Century Group is a plant biotechnology company focused on
technology which allows it to increase or decrease the level of
nicotine in tobacco plants through genetic engineering and plant
breeding. The Company’s mission is to reduce the harm caused by
smoking. 22nd Century owns or exclusively controls 128 issued
patents and 52 pending patent applications in 96 countries. The
Company’s strong IP position led to a licensing agreement with
British American Tobacco (“BAT”), the world’s second largest
tobacco company. Visit www.xxiicentury.com for more
information.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20150522005824/en/
Investor Relations:IRTH CommunicationsAndrew Haag,
866-976-4784xxii@irthcommunications.comorRedington, Inc.Tom
Redington, 203-222-7399
22nd Century (AMEX:XXII)
Historical Stock Chart
From Aug 2024 to Sep 2024
22nd Century (AMEX:XXII)
Historical Stock Chart
From Sep 2023 to Sep 2024